News

In exchange, 3SBio will receive $1.25bn upfront from Pfizer and will be eligible for certain development, regulatory and ...
VML France has announced the appointment of Philippe Huot-Louradour as director of VML Health France. Hout, who has also been ...
Merck & Co – known as MSD outside of the US and Canada – has announced that its Welireg (belzutifan) has been approved by the ...
In an era where clinician time is stretched thin, AI and digital innovation are transforming continuing medical education ...
Understanding why people join clinical trials is essential to improving recruitment and designing better research. Explores ...